MedTrace Logo

Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare Delivery

NCT07222358 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-04-06

No results posted yet for this study

Summary

This feasibility study evaluates a 12-week, multi-component remote assessment program for adult survivors of childhood cancer. The study aims to determine the participation and adherence rates to remote monitoring of cardiometabolic health using wearable devices, surveys, and laboratory testing facilitated by a third-party vendor.

Primary Objective - To establish the feasibility of a multi-component remote assessment program for adult survivors.

* The primary outcome for feasibility will be the participation rate (# eligible survivors approached who enroll) and completion rate (# of eligible survivors who enroll and remain on study through completion).
* An additional outcome for feasibility will be adherence to the multicomponent remote assessment among participants.

Secondary Objective

* To estimate the proportion of participants who complete each individual study component (adherence to each individual component monitoring).

Conditions

  • Childhood Cancer

Interventions

BEHAVIORAL

Remote Monitoring Program

* Participants receive devices (Apple Watch, blood pressure monitor, Continuous Glucose Monitor (CGM), scale, measuring tape). * Monitoring includes ECG, blood pressure, glucose, weight, waist circumference, physical activity, and sleep. * Surveys include health status, medication use, personality traits, and acceptability measures. * One-time blood draw includes CBC, CMP, lipids, HbA1c, NT-proBNP * Food logging during CGM use. * Semi-structured interviews post-study for a subset.

Sponsors & Collaborators

Principal Investigators

  • Stephanie E Dixon, MD, MPH · St. Jude Children's Research Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-08-31
Completion
2027-08-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07222358 on ClinicalTrials.gov